Van Cleef Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.1M Sell
16,793
-575
-3% -$134K 0.44% 34
2025
Q4
$3.59M Sell
17,368
-3,031
-15% -$599K 0.36% 36
2025
Q3
$3.78M Sell
20,399
-202
-1% -$34.6K 0.38% 33
2025
Q2
$3.15M Sell
20,601
-584
-3% -$89.8K 0.34% 37
2025
Q1
$3.51M Sell
21,185
-1,868
-8% -$292K 0.4% 34
2024
Q4
$3.33M Sell
23,053
-234
-1% -$36.3K 0.37% 39
2024
Q3
$3.77M Sell
23,287
-52,465
-69% -$8.36M 0.42% 31
2024
Q2
$11.1M Sell
75,752
-561
-0.7% -$83.4K 1.39% 18
2024
Q1
$12.1M Buy
76,313
+250
+0.3% +$39.8K 1.53% 19
2023
Q4
$11.9M Sell
76,063
-328
-0.4% -$50.3K 1.68% 16
2023
Q3
$11.9M Sell
76,391
-70
-0.1% -$11.6K 1.87% 15
2023
Q2
$12.7M Sell
76,461
-787
-1% -$127K 1.94% 13
2023
Q1
$12M Sell
77,248
-305
-0.4% -$49.2K 1.87% 15
2022
Q4
$13.7M Sell
77,553
-340
-0.4% -$58.7K 2.26% 12
2022
Q3
$12.7M Buy
77,893
+233
+0.3% +$39.4K 2.46% 12
2022
Q2
$13.8M Sell
77,660
-1,007
-1% -$179K 2.33% 11
2022
Q1
$13.9M Buy
78,667
+394
+0.5% +$67K 2.01% 13
2021
Q4
$13.4M Sell
78,273
-1,500
-2% -$246K 1.88% 13
2021
Q3
$12.9M Buy
79,773
+691
+0.9% +$118K 1.94% 14
2021
Q2
$13M Sell
79,082
-2,252
-3% -$373K 1.93% 14
2021
Q1
$13.4M Sell
81,334
-572
-0.7% -$92.6K 2.09% 14
2020
Q4
$12.9M Sell
81,906
-1,002
-1% -$148K 2.11% 13
2020
Q3
$12.3M Sell
82,908
-1,253
-1% -$185K 2.31% 10
2020
Q2
$11.8M Sell
84,161
-890
-1% -$130K 2.41% 9
2020
Q1
$11.2M Buy
85,051
+816
+1% +$116K 2.74% 8
2019
Q4
$12.3M Sell
84,235
-44
-0.1% -$5.97K 2.51% 9
2019
Q3
$10.9M Sell
84,279
-729
-0.9% -$96K 2.4% 11
2019
Q2
$11.8M Sell
85,008
-839
-1% -$116K 2.6% 9
2019
Q1
$12M Buy
85,847
+4,850
+6% +$650K 2.78% 8
2018
Q4
$10.5M Buy
80,997
+909
+1% +$127K 2.79% 9
2018
Q3
$11.1M Sell
80,088
-1,353
-2% -$180K 2.47% 10
2018
Q2
$9.88M Buy
81,441
+1,468
+2% +$183K 2.36% 11
2018
Q1
$10.2M Buy
79,973
+1,316
+2% +$178K 2.53% 10
2017
Q4
$11M Buy
78,657
+137
+0.2% +$19.1K 2.71% 10
2017
Q3
$10.2M Buy
78,520
+1,285
+2% +$170K 2.78% 9
2017
Q2
$10.2M Sell
77,235
-605
-0.8% -$77.2K 2.98% 9
2017
Q1
$9.7M Buy
77,840
+919
+1% +$110K 2.95% 9
2016
Q4
$8.86M Sell
76,921
-584
-0.8% -$67.5K 2.83% 9
2016
Q3
$9.16M Sell
77,505
-745
-1% -$90.4K 3.04% 7
2016
Q2
$9.49M Buy
78,250
+363
+0.5% +$41.2K 3.27% 7
2016
Q1
$8.43M Buy
77,887
+965
+1% +$99.9K 2.98% 8
2015
Q4
$7.9M Buy
76,922
+487
+0.6% +$49K 2.9% 8
2015
Q3
$7.13M Buy
76,435
+3,728
+5% +$361K 2.82% 7
2015
Q2
$7.09M Buy
72,707
+3,355
+5% +$336K 2.64% 9
2015
Q1
$6.98M Sell
69,352
-1,205
-2% -$123K 2.59% 8
2014
Q4
$7.38M Sell
70,557
-265
-0.4% -$27.9K 2.73% 9
2014
Q3
$7.55M Buy
70,822
+1,419
+2% +$147K 3.1% 8
2014
Q2
$7.26M Buy
69,403
+387
+0.6% +$39.1K 3.05% 8
2014
Q1
$6.78M Buy
69,016
+185
+0.3% +$17.2K 2.97% 9
2013
Q4
$6.3M Buy
68,831
+2,440
+4% +$225K 2.77% 11
2013
Q3
$5.75M Sell
66,391
-20
-0% -$1.79K 2.84% 8
2013
Q2
$5.7M Buy
+66,411
New +$5.64M 3.01% 7

Other funds holding JNJ

Van Cleef Asset Management's JNJ Position: Q1 2026 in Review

Van Cleef Asset Management reduced its Johnson & Johnson (JNJ) stake by 3.3% in Q1 2026, selling an estimated $134K and leaving 16,793 shares worth $4.1M. The position accounts for 0.44% of the portfolio, ranked #34.

Van Cleef Asset Management first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.9M in Q1 2022. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Van Cleef Asset Management held 16,793 shares of Johnson & Johnson worth $4.1M as of Q1 2026.
  • Van Cleef Asset Management sold 575 Johnson & Johnson shares in Q1 2026, an estimated $134K.
  • Johnson & Johnson made up 0.44% of Van Cleef Asset Management's portfolio in Q1 2026, its #34 holding.
  • Van Cleef Asset Management first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Van Cleef Asset Management's Johnson & Johnson position peaked at $13.9M in Q1 2022.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Van Cleef Asset Management's 13F filing for Q1 2026, filed 1 May 2026.